Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D.

Lancet Respir Med. 2019 Jul 4. pii: S2213-2600(19)30190-0. doi: 10.1016/S2213-2600(19)30190-0. [Epub ahead of print]

PMID:
31281061
2.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
3.

Measuring Real-Time Team Cognition During Team Training.

Gorman JC, Grimm DA, Stevens RH, Galloway T, Willemsen-Dunlap AM, Halpin DJ.

Hum Factors. 2019 Jun 18:18720819852791. doi: 10.1177/0018720819852791. [Epub ahead of print]

PMID:
31211924
4.

Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease.

Stockley RA, Halpin D, Celli BR, Singh D.

Am J Respir Crit Care Med. 2019 Jul 1;200(1):114-115. doi: 10.1164/rccm.201903-0573LE. No abstract available.

5.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
6.

Using conversational agents to explain medication instructions to older adults.

Azevedo RFL, Morrow D, Graumlich J, Willemsen-Dunlap A, Hasegawa-Johnson M, Huang TS, Gu K, Bhat S, Sakakini T, Sadauskas V, Halpin DJ.

AMIA Annu Symp Proc. 2018 Dec 5;2018:185-194. eCollection 2018.

7.

Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation.

Stockley RA, Halpin DMG, Celli BR, Singh D.

Am J Respir Crit Care Med. 2019 May 15;199(10):1195-1204. doi: 10.1164/rccm.201810-1860SO.

PMID:
30592902
8.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
9.

Inhalation Devices.

Moroni-Zentgraf P, Usmani OS, Halpin DMG.

Can Respir J. 2018 Sep 18;2018:5642074. doi: 10.1155/2018/5642074. eCollection 2018. No abstract available.

10.

Understanding irrationality: the key to changing behaviours and improving management of respiratory diseases?

Halpin DMG.

Lancet Respir Med. 2018 Oct;6(10):737-739. doi: 10.1016/S2213-2600(18)30364-3. Epub 2018 Sep 26. No abstract available.

PMID:
30303088
11.

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A.

Respir Res. 2018 Oct 5;19(1):196. doi: 10.1186/s12931-018-0874-0.

12.

The maiming fields of Gaza.

Summerfield D, Halpin D, Ang S, Balduzzi A, Camandona F, Tognoni G, Bono I, Rui M, Agnoletto V.

BMJ. 2018 Aug 13;362:k3299. doi: 10.1136/bmj.k3299. No abstract available.

PMID:
30104202
13.

mHealth resources for asthma and pregnancy care: Methodological issues and social media recruitment. A discussion paper.

Williamson GR, O'Connor A, Chamberlain C, Halpin D.

J Adv Nurs. 2018 Oct;74(10):2442-2449. doi: 10.1111/jan.13773. Epub 2018 Jul 17.

PMID:
29943472
14.

Palliative Care for Chronic Obstructive Pulmonary Disease. Signs of Progress, but Still a Long Way to Go.

Halpin DMG.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1356-1358. doi: 10.1164/rccm.201805-0955ED. No abstract available.

PMID:
29889550
15.

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.

Halpin DMG, Birk R, Brealey N, Criner GJ, Dransfield MT, Hilton E, Lomas DA, Zhu CQ, Lipson DA.

ERJ Open Res. 2018 May 4;4(2). pii: 00119-2017. doi: 10.1183/23120541.00119-2017. eCollection 2018 Apr.

16.

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Martinez FJ, Singh D, Tabberer M, Wise RA, Pascoe SJ; IMPACT Investigators.

N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18.

17.

Palliative care for people with COPD: effective but underused.

Halpin DMG.

Eur Respir J. 2018 Feb 14;51(2). pii: 1702645. doi: 10.1183/13993003.02645-2017. Print 2018 Feb. No abstract available.

PMID:
29444923
18.

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.

Miravitlles M, Roche N, Cardoso J, Halpin D, Aisanov Z, Kankaanranta H, Kobližek V, Śliwiński P, Bjermer L, Tamm M, Blasi F, Vogelmeier CF.

Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1. Review.

19.

The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease.

Halpin DMG.

Tuberc Respir Dis (Seoul). 2018 Jan;81(1):13-18. doi: 10.4046/trd.2017.0098. Review.

20.

Impact and prevention of severe exacerbations of COPD: a review of the evidence.

Halpin DM, Miravitlles M, Metzdorf N, Celli B.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 5;12:2891-2908. doi: 10.2147/COPD.S139470. eCollection 2017. Review.

21.

Clinician Perceptions of 4 Hearing Protection Devices.

Spomer J, Estrich CG, Halpin D, Lipman RD, Araujo MWB.

JDR Clin Trans Res. 2017 Oct;2(4):363-369. doi: 10.1177/2380084417715599. Epub 2017 Jun 19.

PMID:
30931750
22.

When is dual bronchodilation indicated in COPD?

Thomas M, Halpin DM, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2291-2305. doi: 10.2147/COPD.S138554. eCollection 2017. Review.

23.

Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49].

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, Varela MVL, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Jul;53(7):411-412. doi: 10.1016/j.arbres.2017.06.001. English, Spanish. No abstract available.

24.

Effect of a single exacerbation on decline in lung function in COPD.

Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP.

Respir Med. 2017 Jul;128:85-91. doi: 10.1016/j.rmed.2017.04.013. Epub 2017 Apr 24.

25.

Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.

Halpin DM, Kaplan AG, Russell RK.

Respir Med. 2017 Jul;128:28-41. doi: 10.1016/j.rmed.2017.04.008. Epub 2017 Apr 18. Review.

26.

Review of coronary subclavian steal syndrome.

Cua B, Mamdani N, Halpin D, Jhamnani S, Jayasuriya S, Mena-Hurtado C.

J Cardiol. 2017 Nov;70(5):432-437. doi: 10.1016/j.jjcc.2017.02.012. Epub 2017 Apr 14. Review.

27.

Management of Isolated Atherosclerotic Stenosis of the Common Femoral Artery: A Review of the Literature.

Halpin D, Erben Y, Jayasuriya S, Cua B, Jhamnani S, Mena-Hurtado C.

Vasc Endovascular Surg. 2017 May;51(4):220-227. doi: 10.1177/1538574417702773. Epub 2017 Apr 4. Review.

PMID:
28376704
28.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Jul;53(7):411-412.

29.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Eur Respir J. 2017 Mar 6;49(3). pii: 1700214. doi: 10.1183/13993003.00214-2017. Print 2017 Mar. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

30.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

31.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

32.

Preference for different relaxation techniques by COPD patients: comparison between six techniques.

Hyland ME, Halpin DM, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves CJ, Hawkins AL, Seamark D.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2315-2319. eCollection 2016.

33.

Tiotropium in asthma: what is the evidence and how does it fit in?

Halpin DM.

World Allergy Organ J. 2016 Sep 14;9(1):29. doi: 10.1186/s40413-016-0119-y. eCollection 2016. Review.

34.

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.

Halpin DM, Kerkhof M, Soriano JB, Mikkelsen H, Price DB.

Respir Res. 2016 Sep 23;17(1):120.

35.

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.

Singh D, Roche N, Halpin D, Agusti A, Wedzicha JA, Martinez FJ.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):541-9. doi: 10.1164/rccm.201606-1179PP.

36.

Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.

Dahl R, Engel M, Dusser D, Halpin D, Kerstjens HAM, Zaremba-Pechmann L, Moroni-Zentgraf P, Busse WW, Bateman ED.

Respir Med. 2016 Sep;118:102-111. doi: 10.1016/j.rmed.2016.07.001. Epub 2016 Jul 2.

37.

Effect of tiotropium on COPD exacerbations: A systematic review.

Halpin DM, Vogelmeier C, Pieper MP, Metzdorf N, Richard F, Anzueto A.

Respir Med. 2016 May;114:1-8. doi: 10.1016/j.rmed.2016.02.012. Epub 2016 Mar 2. Review.

38.

Case finding for chronic obstructive pulmonary disease in people attending long-term condition clinics in primary care.

Halpin D, Holmes S, Calvert J, McInerney D.

Chron Respir Dis. 2016 Nov;13(4):337-343. doi: 10.1177/1479972316643011. Epub 2016 Jul 8.

39.

Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.

Lange P, Halpin DM, O'Donnell DE, MacNee W.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss:3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Review.

40.

A review of national guidelines for management of COPD in Europe.

Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandström T, Śliwiński P, Zatloukal J, Blasi F.

Eur Respir J. 2016 Feb;47(2):625-37. doi: 10.1183/13993003.01170-2015. Epub 2016 Jan 21. Review.

41.

Understanding fear and anxiety in patients at the time of an exacerbation of chronic obstructive pulmonary disease: a qualitative study.

Halpin D, Hyland M, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves C, Hawkins A, Seamark D.

JRSM Open. 2015 Nov 18;6(12):2054270415614543. doi: 10.1177/2054270415614543. eCollection 2015 Dec.

42.

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

Paggiaro P, Halpin DM, Buhl R, Engel M, Zubek VB, Blahova Z, Moroni-Zentgraf P, Pizzichini E.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):104-13.e2. doi: 10.1016/j.jaip.2015.08.017. Epub 2015 Nov 7.

43.

Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial.

Halpin DMG, Tashkin DP, Celli BR, Leimer I, Metzdorf N, Decramer M.

Chronic Obstr Pulm Dis. 2015 Jun 23;2(3):236-251. doi: 10.15326/jcopdf.2.3.2014.0142.

44.

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.

Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 5;10:239-59. doi: 10.2147/COPD.S75146. eCollection 2015.

45.

Investigating Women's Experiences of Asthma Care in Pregnancy: A Qualitative Study.

Chamberlain C, Williamson GR, Knight B, Daly M, Halpin DM.

Open Nurs J. 2014 Dec 11;8:56-63. doi: 10.2174/1874434601408010056. eCollection 2014.

46.

A retrospective study of the impact of a telephone alert service (Healthy Outlook) on hospital admissions for patients with chronic obstructive pulmonary disease.

Sarran C, Halpin D, Levy ML, Prigmore S, Sachon P.

NPJ Prim Care Respir Med. 2014 Oct 23;24:14080. doi: 10.1038/npjpcrm.2014.80.

47.

The WISDOM of inhaled corticosteroids in COPD.

Halpin DM, Quint JK.

Thorax. 2014 Dec;69(12):1071-2. doi: 10.1136/thoraxjnl-2014-206333. Epub 2014 Oct 16. No abstract available.

48.

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.

Tashkin DP, Li N, Kleerup EC, Halpin D, Celli B, Decramer M, Elashoff R.

Respir Res. 2014 Aug 31;15:102. doi: 10.1186/s12931-014-0102-5.

49.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group.

Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13.

50.

Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.

Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R.

Respir Med. 2013 Dec;107(12):1904-11. doi: 10.1016/j.rmed.2013.08.001. Epub 2013 Aug 22.

Supplemental Content

Loading ...
Support Center